Medicare’s AI Expansion Sparks Fear and Fury

Wooden block with MEDICARE text next to a stethoscope — ALARMING MEDICARE CHANGE

The federal government is preparing to force Medicare patients to rely on AI algorithms, which have already been accused of systematically denying necessary medical care to Americans in private insurance plans.

Story Highlights

Medicare will pilot AI-driven prior authorization starting January 2026, mirroring controversial private insurer practices
Class-action lawsuits target United Healthcare and Humana for allegedly using AI to wrongfully deny patient care
61% of physicians report AI is increasing prior authorization denials and harming patients
The pilot program will run through 2031 in six states with minimal oversight mechanisms

Government Expands AI Gatekeeping to Medicare

The Centers for Medicare and Medicaid Services announced a pilot program that will bring artificial intelligence into Medicare’s prior authorization process beginning January 2026.

The program will run through 2031 in six states, essentially importing the same controversial AI systems that private insurers like United Healthcare and Humana have used to deny care.

This represents a fundamental shift for traditional Medicare, which has historically operated without the extensive prior authorization barriers that have plagued Medicare Advantage plans and private insurance.

CMS Administrator Mehmet Oz acknowledged existing delays and concerns with prior authorization, yet the agency is moving forward with AI automation rather than addressing the underlying problems.

The pilot program lacks robust safeguards against the systematic denials that have triggered multiple class-action lawsuits in the private sector. This expansion of government control over healthcare decisions should alarm anyone concerned about bureaucratic overreach and the erosion of the doctor-patient relationship.

Private Insurers Face Legal Challenges Over AI Denials

Major health insurers are defending themselves against multiple lawsuits alleging their AI systems, particularly the nHPredict algorithm, systematically deny necessary medical care.

United Healthcare and Humana face class-action suits claiming their artificial intelligence models override physician recommendations and create barriers to essential treatment, especially for elderly and chronically ill patients. These cases represent some of the first major legal challenges to AI-driven healthcare decision-making in America.

The lawsuits paint a disturbing picture of automated batch denials with minimal human oversight, despite insurer claims of maintaining “human in the loop” processes.

Humana and United Healthcare have refused to comment on the litigation, but internal documents and whistleblower accounts suggest these AI systems prioritize cost containment over patient care.

The companies’ reluctance to provide transparency about their algorithms raises serious questions about accountability and due process in healthcare coverage decisions.

Physicians Report Widespread Patient Harm

A recent American Medical Association survey found that 61% of physicians believe AI-enabled prior authorization is increasing denials and harming patients.

Medical professionals report spending excessive time fighting algorithmic decisions that delay or prevent necessary treatments, creating administrative burdens that take time away from patient care.

AMA President Bruce A. Scott emphasized that medical decisions should remain with clinicians, not computer algorithms programmed by insurance company executives.

The survey results confirm what many doctors have observed: AI systems often lack the clinical nuance required for complex medical decisions and tend to apply rigid cost-cutting criteria regardless of individual patient needs.

Physicians describe cases where life-saving treatments are delayed or denied based on algorithmic determinations that ignore crucial clinical context. This represents a fundamental threat to medical autonomy and the traditional American healthcare model where doctors and patients make treatment decisions together.

Regulatory Oversight Remains Inadequate

Despite mounting evidence of problems with AI-driven healthcare decisions, federal regulators have failed to establish meaningful oversight mechanisms.

The upcoming Medicare pilot program proceeds without comprehensive safeguards against the systematic abuses documented in private insurance.

Industry trade groups like AHIP have made vague commitments to improving transparency and reducing prior authorization scope, but these promises lack enforcement mechanisms or specific timelines.

The regulatory vacuum allows insurance companies and now government programs to implement AI systems with minimal accountability to patients or physicians.

This represents exactly the kind of unchecked bureaucratic expansion that undermines individual liberty and healthcare freedom.

Americans deserve transparent, accountable healthcare decisions, not algorithmic black boxes that prioritize cost savings over human welfare while hiding behind claims of proprietary technology.